Keyword Analysis & Research: genelux
Keyword Research: People who searched genelux also searched
Search Results related to genelux on Search Engine
-
Genelux Corporation | Redefining Immuno-Oncology
https://genelux.com/
WEBGenelux Corporation is committed to developing safe and effective next-generation immunotherapies for patients suffering from aggressive and/or difficult-to-treat solid tumor types. Our goal is to ensure access to our investigational therapies at the appropriate time and in a clinically appropriate manner for patients.
DA: 61 PA: 74 MOZ Rank: 28
-
Genelux Corporation | Pipeline
https://genelux.com/overview/
WEBOverview. We are dedicated to developing a pipeline of next-generation immunotherapies for patients suffering with aggressive and/or difficult-to-treat solid tumor types. Information about our investigational products and clinical trials can be found here and clinicaltrials.gov.
DA: 28 PA: 80 MOZ Rank: 57
-
Genelux Corporation | Company
https://genelux.com/about/
WEBCompany. Vision and Mission. Our vision is to build a pre-eminent immuno-oncology company that addresses serious unmet medical needs. Our mission is to develop immunotherapeutics that deliver the full complement of tumor neo-antigens with the power to stimulate a personalized immune system response to fight cancer, individual by individual.
DA: 70 PA: 80 MOZ Rank: 16
-
Genelux Corporation (GNLX) Stock Price, Quote & News - Stock …
https://stockanalysis.com/stocks/gnlx/
WEBApr 15, 2024 · Get a real-time Genelux Corporation (GNLX) stock price quote with breaking news, financials, statistics, charts and more.
DA: 81 PA: 12 MOZ Rank: 90
-
Genelux Corporation (GNLX) - Yahoo Finance
https://finance.yahoo.com/quote/GNLX
WEBGenelux Corporation, a clinical-stage biopharmaceutical company, focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive and/or...
DA: 19 PA: 92 MOZ Rank: 71
-
Genelux Corporation - Wikipedia
https://en.wikipedia.org/wiki/Genelux_Corporation
WEBU.S. Products. Olvi-Vec. Website. www.genelux.com. Genelux Corporation is a late clinical-stage public company (Nasdaq: GNLX) developing a pipeline of next-generation oncolytic viral immunotherapies for patients suffering from aggressive …
DA: 1 PA: 26 MOZ Rank: 11
-
Genelux Corporation Initiates a Pivotal Phase 3 Trial,
https://www.globenewswire.com/news-release/2022/09/21/2520149/0/en/Genelux-Corporation-Initiates-a-Pivotal-Phase-3-Trial-Evaluating-Olvi-Vec-for-the-treatment-of-Platinum-Resistant-Refractory-Ovarian-Cancer.html
WEBSep 21, 2022 · WESTLAKE VILLAGE, Calif., Sept. 21, 2022 (GLOBE NEWSWIRE) -- Genelux Corporation, a clinical-stage immunotherapy company, announced today that it has initiated OnPrime, a multi-center,...
DA: 95 PA: 51 MOZ Rank: 83
-
Genelux Corporation | News Releases
https://investors.genelux.com/news-events/news-releases
WEBSep 14, 2023 · Genelux Corporation Reports Second Quarter 2023 Financial Results and Provides General Business Updates. - Inclusion into the broad-market Russell 3000® Index and small-cap Russell 2000® Index - - Publication of VIRO-15 Phase 2 data in JAMA Oncology - - $51 Million raised after closing of two private placements in Q2, totaling $65 million ...
DA: 6 PA: 60 MOZ Rank: 34
-
Genelux Corporation | Genelux Corporation Receives FDA Fast …
https://investors.genelux.com/news-releases/news-release-details/genelux-corporation-receives-fda-fast-track-designation-olvi-vec
WEBNov 27, 2023 · WESTLAKE VILLAGE, Calif., Nov. 27, 2023 (GLOBE NEWSWIRE) -- Genelux Corporation (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced that the United States Food and Drug Administration (FDA) has granted Fast Track designation for the development program of Olvi-Vec (olvimulogene nanivacirepvec) for …
DA: 58 PA: 69 MOZ Rank: 35
-
Genelux Corporation Announces Pricing of Initial Public Offering
https://finance.yahoo.com/news/genelux-corporation-announces-pricing-initial-020000661.html
WEBJan 26, 2023 · Genelux is a clinical-stage biopharmaceutical company focused on developing a pipeline of next-generation oncolytic immunotherapies for patients suffering from aggressive and/or...
DA: 12 PA: 70 MOZ Rank: 57